Physician profile
Nara Lee
NPI 1881093813
$3,367.23
in general payments reported to CMS, 2019-2025
20 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,501 · 2020: $318 · 2021: $288 · 2022: $291 · 2023: $644 · 2024: $132 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610 · Honoraria: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.42 |
| Honoraria | $360.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $492.45 | 2019-2022 | |
| Celgene Corporation | $377.31 | 2019-2020 | |
| Daiichi Sankyo INC. | $360.00 | 2023 | |
| Genentech USA, INC. | $280.59 | 2019 | |
| Incyte Corporation | $249.10 | 2021 | |
| Janssen Biotech, INC. | $244.35 | 2019 | |
| Secura Bio, INC. | $226.52 | 2023-2024 | Copiktra |
| Sobi, INC | $193.74 | 2025 | |
| Amgen INC. | $173.39 | 2019 | |
| Jazz Pharmaceuticals INC. | $143.07 | 2019-2020 | |
| Stryker Corporation | $133.60 | 2023 | Xpress Ent Dilation System, 1788, Spy-Phi System |
| Regeneron Healthcare Solutions, INC. | $118.26 | 2022 | |
| Genzyme Corporation | $111.47 | 2019 | |
| Pfizer INC. | $107.65 | 2021-2022 | |
| Exelixis INC. | $35.80 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beigene USA, INC. | $34.65 | 2023-2024 | Brukinsa |
| Seagen INC. | $25.19 | 2020 | |
| Abbvie INC. | $21.91 | 2023 | |
| Alexion Pharmaceuticals, INC. | $20.41 | 2020 | |
| Terumo Bct, INC. | $17.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nara Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.